Efectos nocivos del cigarrillo electrónico para la salud humana. Una revisión

Harmful effects of electronic cigarette on human health. A review

Publicado 2023-06-01

Abrir | Descargar
PDF FLIP
Número
Vol. 35 Núm. 1 (2023): .
Sección
Revisión de tema
Cómo citar
Efectos nocivos del cigarrillo electrónico para la salud humana. Una revisión.
rev. colomb. neumol. [Internet]. 2023 Jun. 1 [cited 2024 Dec. 22];35(1):46-6. Disponible en: https://doi.org/10.30789/rcneumologia.v35.n1.2023.604
DOI

https://doi.org/10.30789/rcneumologia.v35.n1.2023.604
Dimensions
PlumX
Licencia

Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo  los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.

Mariana Usuga David
Fundacion universitaria San Martin. Facultad de Medicina
    https://orcid.org/0000-0003-0938-1404
    Mostrar biografía de los autores

    Mariana Usuga David,

    Docente de la Facultad de medicina de la Fundacion Universitaria San Martin, sede de sabaneta. Magister en Drogodependencia universidad CES y Médica de la Fundacion Universitaria San Martin, sede Sabaneta

    El cigarrillo electrónico es un dispositivo electrónico capaz de liberar nicotina y algunas otras sustancias toxicas y carcinogénicas, sin embargo, existen dispositivos que no generan nicotina llamados Sistemas Electrónicos Sin Suministro de Nicotina (SSSN). Fue creado en el 2003 en China y posteriormente se ha ido comercializando en el resto del mundo, con diferentes generaciones y marcas del dispositivo. En realidad, existe una falsa percepción frente a este cigarrillo, porque no se ve expuesto a los efectos dañinos que tiene el cigarrillo de tabaco, lo que aumenta su uso en población adolescente quienes además se ven atraídos por la forma, los saborizantes y el color del dispositivo, volviéndolo incluso más aceptado socialmente. Además, existen países que aún no cuentan con políticas y normas para la comercialización del cigarrillo electrónico; razón por la cual el uso de este dispositivo es cada vez mayor. El dispositivo se comercializa con la idea de que es una herramienta eficaz para dejar de fumar, pero en realidad faltan estudios que avalen dicha información. Es muy importante que los usuarios de dichos dispositivos conozcan y sean conscientes de las enfermedades atribuibles a los compuestos tóxicos de los cigarrillos electrónicos. Este artículo es una adaptación del trabajo de grado presentado para la Maestría en Drogodependencia de la autora.

    Visitas del artículo 3759 | Visitas PDF 5399

    Descargas

    Los datos de descarga todavía no están disponibles.
    1. Soneji S, Barrington-Trimis JL, Wills TA, Leventhal AM, Unger JB, Gibson LA, et al. Association Between Initial Use of e-Cigarettes and Subsequent Cigarette Smoking Among Adolescents and Young Adults: A Systematic Review and Meta-analysis. JAMA Pediatr. 2017;171(8):788. doi: 10.1001/jamapediatrics.2017.1488
    2. Gómez-Restrepo C, Cabarique Méndez CA, Marroquín A, Botero-Rodríguez F, Leal A. Con respecto al día mundial sin tabaco, ¿los cigarrillos electrónicos pueden afectar la salud y la salud mental? Rev Colomb Psiquiatr. julio de 2019;48(3):131-2. doi: 10.1016/j.rcp.2019.06.001
    3. Thirión-Romero I, Pérez-Padilla R, Zabert G, Barrientos-Gutiérrez I. Respiratory impact of electronic cigarettes and «low-risk» tobacco. Rev Investig Clin Organo Hosp Enfermedades Nutr. 2019;71(1):17-17-27. doi: 10.24875/RIC.18002616
    4. Goniewicz ML, Kuma T, Gawron M, Knysak J, Kosmider L. Nicotine Levels in Electronic Cigarettes. Nicotine Tob Res. 2013;15(1):158-66. doi: 10.1093/ntr/nts103
    5. Herzog B, Kanada P. Nielsen: Tobacco All Channel BiWeekly Data Thru 11/17 [Internet]. 2018. Disponible en: https://athra.org.au/wp-content/uploads/2018/12/Wells-Fargo-Nielsen-Tobacco-All-Channel-BiWeekly-Report-Period-Ending-11.17.18.pdf
    6. Gotts JE, Jordt S-E, McConnell R, Tarran R. What are the respiratory effects of e-cigarettes? BMJ. 2019;366. doi: 10.1136/bmj.l5275
    7. King BA, Gammon DG, Marynak KL, Rogers T. Electronic Cigarette Sales in the United States, 2013-2017. JAMA. 2018;320(13):1379-80. doi: 10.1001/jama.2018.10488
    8. Huang J, Duan Z, Kwok J, Binns S, Vera LE, Kim Y, et al. Vaping versus JUULing: how the extraordinary growth and marketing of JUUL transformed the US retail e-cigarette market. Tob Control. 2019;28(2):146-51. doi: 10.1136/tobaccocontrol-2018-054382
    9. Willett JG, Bennett M, Hair EC, Xiao H, Greenberg MS, Harvey E, et al. Recognition, use and perceptions of JUUL among youth and young adults. Tob Control. 2019;28(1):115-6. doi: 10.1136/tobaccocontrol-2018-054273
    10. Baca MC. How two Stanford grads aimed for Big Tech glory and got Big Tobacco instead. Washington Post [Internet]. 2019 [citado 12 de septiembre de 2020]; Disponible en: https://www.washingtonpost.com/technology/2019/09/04/how-two-stanford-grads-aimed-big-tech-glory-got-big-tobacco-instead/
    11. Schaller K, Ruppert L, Kahnert S, Bethke C, Nair U, Pötschke-Langer M. Electronic Cigarettes – An Overview [Internet]. Heidelberg: German Cancer Research Center (DKFZ); 2013 [citado el 4 de mayo de 2023]. (Red Series Tobacco Prevention and Tobacco Control). No.: 19. Disponible en: http://www.asat.org.ar/images/comunidad/publicaciones/e-cigarettes_german_cancer_center.pdf
    12. Wang TW. Tobacco Product Use Among Adults — United States, 2017. MMWR Morb Mortal Wkly Rep. 2018. doi: 10.15585/mmwr.mm6744a2
    13. Gottlieb MA. Regulation of E-Cigarettes in the United States and Its Role in a Youth Epidemic. Child Basel Switz. 2019;6(3):1-6 . doi: 10.3390/children6030040
    14. Leventhal AM, Strong DR, Kirkpatrick MG, Unger JB, Sussman S, Riggs NR, et al. Association of Electronic Cigarette Use With Initiation of Combustible Tobacco Product Smoking in Early Adolescence. JAMA.2015;314(7):700-7. doi: 10.1001/jama.2015.8950
    15. Zhu S-H, Zhuang Y-L, Wong S, Cummins SE, Tedeschi GJ. E-cigarette use and associated changes in population smoking cessation: evidence from US current population surveys. BMJ. 2017;j3262. doi: 10.1136/bmj.j3262
    16. Barrington-Trimis JL, Urman R, Berhane K, Unger JB, Cruz TB, Pentz MA, et al. E-Cigarettes and Future Cigarette Use. Pediatrics. julio de 2016;138(1):e20160379. doi: 10.1542/peds.2016-0379
    17. National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General [Internet]. Atlanta (GA): Centers for Disease Control and Prevention (US); 2014 [citado 11 de septiembre de 2020]. (Reports of the Surgeon General). Disponible en: http://www.ncbi.nlm.nih.gov/books/NBK179276/
    18. National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. E-Cigarette Use Among Youth and Young Adults: A Report of the Surgeon General [Internet]. Atlanta (GA): Centers for Disease Control and Prevention (US); 2016 [citado 8 de noviembre de 2022]. (Publications and Reports of the Surgeon General). Disponible en: http://www.ncbi.nlm.nih.gov/books/NBK538680
    19. White J, Li J, Newcombe R, Walton D. Tripling use of electronic cigarettes among New Zealand adolescents between 2012 and 2014. J Adolesc Health Off Publ Soc Adolesc Med. 2015;56(5):522-8. doi: 10.1016/j.jadohealth.2015.01.022
    20. Dautzenberg B, Berlin I, Tanguy ML, Rieu N, Birkui P. Factors associated with experimentation of electronic cigarettes among Parisian teenagers in 2013. Tob Induced Dis. 2015;13(1):40. doi: 10.1186/s12971-015-0065-4
    21. Lotrean LM. Use of electronic cigarettes among Romanian university students: a cross-sectional study. BMC Public Health. 2015;15(1):358. doi: 10.1186/s12889-015-1713-6
    22. Kinnunen JM, Ollila H, El-Amin SET, Pere LA, Lindfors PL, Rimpelä AH. Awareness and determinants of electronic cigarette use among Finnish adolescents in 2013: a population-based study. Tob Control. 2015;24(e4):e264–70. doi: 10.1136/tobaccocontrol-2013-051512
    23. Czoli CD, Hammond D, White CM. Electronic cigarettes in Canada: Prevalence of use and perceptions among youth and young adults. Can J Public Health. 2014;105(2):e97–102. doi: 10.17269/cjph.105.4119
    24. Hughes K, Bellis MA, Hardcastle KA, McHale P, Bennett A, Ireland R, et al. Associations between e-cigarette access and smoking and drinking behaviours in teenagers. BMC Public Health. 2015;15:244. doi: 10.1186/s12889-015-1618-4
    25. Goniewicz ML, Zielinska-Danch W. Electronic cigarette use among teenagers and young adults in Poland. Pediatrics. 2012;130(4):e879-885. doi: 10.1542/peds.2011-3448
    26. Thrasher JF, Abad-Vivero EN, Barrientos-Gutierrez I, Pérez-Hernández R, Reynales-Shigematsu LM, Mejía R, et al. Prevalence and correlates of e-cigarette perceptions and trial among Mexican adolescents. J Adolesc Health Off Publ Soc Adolesc Med. 2016;58(3):358-65. doi: 10.1016/j.jadohealth.2015.11.008
    27. Oficina de las Naciones Unidas Contra la Droga y el Delito (UNODC). III Estudio epidemiológico andino sobre consumo de drogas en la población universitaria, Informe Regional, 2016 [Internet]. UNODC; 2017. Disponible en: https://www.unodc.org/documents/peruandecuador/Informes/Otros/Informe_Universitario_Regional.pdf
    28. Pulido Álvarez A, Pinzón Silva DC, Rodríguez NI, Sandoval Salinas C, Pinzón Flórez CE, Díaz Ortega MH, et al. Opciones en Colombia para la regulación del uso de sistemas electrónicos con o sin dispensación de nicotina: un resumen de evidencias para política (policy brief). Opciones En Colomb Para Regul Uso Sist Electrónicos Con O Sin Dispens Nicotina Un Resum Evid Para Política Policy Brief [Internet]. 2018 [citado 16 de julio de 2020];1-59. Disponible en: http://www.iets.org.co/Archivos/3/Policy_brief_version_completa.pdf
    29. E-Cigarettes: FDA Regulation Looms for $1.5 Billion Industry - Bloomberg [Internet]. [citado 25 de septiembre de 2020]. Disponible en: https://www.bloomberg.com/news/articles/2014-02-06/e-cigarettes-fda-regulation-looms-for-1-dot-5-billion-industry
    30. Alvear T. G, Santibáñez S. L, Ramírez S. V, Sepúlveda M. R, Alvear T. G, Santibáñez S. L, et al. Cigarrillos eléctrónicos. ¿Podemos recomendar su uso? Revista chilena de enfermedades respiratorias. 2017;33(2):118–30. doi: 10.4067/s0717-73482017000200118
    31. Caponnetto P, Campagna D, Cibella F, Morjaria JB, Caruso M, Russo C, et al. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as Tobacco Cigarettes Substitute: A Prospective 12-Month Randomized Control Design Study. Le Foll B, editor. PLoS ONE. 2013;8(6):e66317. doi: 10.1371/annotation/e12c22d3-a42b-455d-9100-6c7ee45d58d0
    32. Cheng T. Chemical evaluation of electronic cigarettes. Tob Control. 2014;23(suppl 2):ii11–7. doi: 10.1136/tobaccocontrol-2013-051482
    33. Smith MR, Clark B, Lüdicke F, Schaller J-P, Vanscheeuwijck P, Hoeng J, et al. Evaluation of the Tobacco Heating System 2.2. Part 1: Description of the system and the scientific assessment program. Regul Toxicol Pharmacol. 2016;81:S17-26. doi: 10.1016/j.yrtph.2016.07.006
    34. Chun LF, Moazed F, Calfee CS, Matthay MA, Gotts JE. Pulmonary toxicity of e-cigarettes. Am J Physiol - Lung Cell Mol Physiol. 2017;313(2):L193-206. doi: 10.1152/ajplung.00071.2017
    35. Hadwiger ME, Trehy ML, Ye W, Moore T, Allgire J, Westenberger B. Identification of amino-tadalafil and rimonabant in electronic cigarette products using high pressure liquid chromatography with diode array and tandem mass spectrometric detection. J Chromatogr A. 2010;1217(48):7547-55. doi: 10.1016/j.chroma.2010.10.018
    36. Allen JG, Flanigan SS, LeBlanc M, Vallarino J, MacNaughton P, Stewart JH, et al. Flavoring Chemicals in E-Cigarettes: Diacetyl, 2,3-Pentanedione, and Acetoin in a Sample of 51 Products, Including Fruit-, Candy-, and Cocktail-Flavored E-Cigarettes. Environ Health Perspect. junio de 2016;124(6):733-9. doi: 10.1289/ehp.1510185
    37. Klager S, Vallarino J, MacNaughton P, Christiani DC, Lu Q, Allen JG. Flavoring Chemicals and Aldehydes in E-Cigarette Emissions. Environ Sci Technol. 19 de septiembre de 2017;51(18):10806-13. doi: 10.1021/acs.est.7b02205
    38. Zhu S-H, Sun JY, Bonnevie E, Cummins SE, Gamst A, Yin L, et al. Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation. Tob Control [Internet]. julio de 2014;23(suppl 3):iii3-9. doi: 10.1136/tobaccocontrol-2014-051670
    39. Kong G, Morean ME, Cavallo DA, Camenga DR, Krishnan-Sarin S. Reasons for Electronic Cigarette Experimentation and Discontinuation Among Adolescents and Young Adults. Nicotine Tob Res Off J Soc Res Nicotine Tob. 2015;17(7):847-54. doi: 10.1093/ntr/ntu257
    40. Dinardo P, Rome ES. Vaping: The new wave of nicotine addiction. Cleve Clin J Med. 2019;86(12):789-98. doi: 10.3949/ccjm.86a.19118
    41. Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014;23(2):133-9. doi: 10.1136/tobaccocontrol-2012-050859
    42. Prochaska JJ. The public health consequences of e‐cigarettes: a review by the National Academies of Sciences. A call for more research, a need for regulatory action. Addiction. 2019;114(4):587-9. doi: 10.1111/add.14478
    43. Boulay M-È, Henry C, Bossé Y, Boulet L-P, Morissette MC. Acute effects of nicotine-free and flavour-free electronic cigarette use on lung functions in healthy and asthmatic individuals. Respir Res. 2017;18(1):33. doi: 10.1186/s12931-017-0518-9
    44. Ghosh A, Coakley RC, Mascenik T, Rowell TR, Davis ES, Rogers K, et al. Chronic E-Cigarette Exposure Alters the Human Bronchial Epithelial Proteome. Am J Respir Crit Care Med. 01 de 2018;198(1):67-76. doi: 10.1164/rccm.201710-2033OC
    45. Carter T, Tucker D, Kilic A, Papadimos TJ, Barlow A, Berry E. Life-threatening Vesicular Bronchial Injury Requiring Veno-venous Extracorporeal Membrane Oxygenation Rescue in an Electronic Nicotine Delivery System User. Clin Pract Cases Emerg Med. 2017;1(3):212-7. doi: 10.5811/cpcem.2017.3.33171
    46. Lappas AS, Tzortzi AS, Konstantinidi EM, Teloniatis SI, Tzavara CK, Gennimata SA, et al. Short-term respiratory effects of e-cigarettes in healthy individuals and smokers with asthma. Respirol Carlton Vic. 2018;23(3):291-7. doi: 10.1111/resp.13180
    47. Schweitzer RJ, Wills TA, Tam E, Pagano I, Choi K. E-cigarette use and asthma in a multiethnic sample of adolescents. Prev Med. 2017;105:226-31. doi: 10.1016/j.ypmed.2017.09.023
    48. Reid KM. Tobacco Product Use Among Youths With and Without Lifetime Asthma — Florida, 2016. MMWR Morb Mortal Wkly Rep. 2018;67. doi: 10.15585/mmwr.mm6721a2
    49. Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V. Characteristics, Perceived Side Effects and Benefits of Electronic Cigarette Use: A Worldwide Survey of More than 19,000 Consumers. Int J Environ Res Public Health. 2014;11(4):4356-73. doi: 10.3390/ijerph110404356
    50. Callahan-Lyon P. Electronic cigarettes: human health effects. Tobacco Control. 2014;23(suppl 2):ii36–40. doi: 10.1136/tobaccocontrol-2013-051470
    51. The National Institute for Occupational Safety and Health (NIOSH). Exposures to Flavoring Chemicals [Internet]. 2017 [citado el 16 de agosto de 2020]. Disponible en: https://www.cdc.gov/niosh/topics/flavorings/exposure.html
    52. Glasser AM, Katz L, Pearson JL, Abudayyeh H, Niaura RS, Abrams DB, et al. Overview of Electronic Nicotine Delivery Systems: A Systematic Review. Am J Prev Med. 2017;52(2):e33-66. doi: 10.1016/j.amepre.2016.10.036
    53. Allen JG, Flanigan SS, LeBlanc M, Vallarino J, MacNaughton P, Stewart JH, et al. Flavoring Chemicals in E-Cigarettes: Diacetyl, 2,3-Pentanedione, and Acetoin in a Sample of 51 Products, Including Fruit-, Candy-, and Cocktail-Flavored E-Cigarettes. Environ Health Perspect. 2016;124(6):733-9. doi: 10.1016/j.amepre.2016.10.036
    54. Laino T, Tuma C, Moor P, Martin E, Stolz S, Curioni A. Mechanisms of propylene glycol and triacetin pyrolysis. J Phys Chem A. 2012;116(18):4602-9. doi: 10.1021/jp300997d
    55. McCauley L, Markin C, Hosmer D. An Unexpected Consequence of Electronic Cigarette Use. CHEST. 2012;141(4):1110-3. doi: 10.1378/chest.11-1334
    56. Alfa Chemistry Analytical Products. 56-81-5 - Analytical Products [Internet]. 2023 [citado el 12 de agosto de 2020]. Disponible en: https://reagents.alfa-chemistry.com/search?q=56-81-5&gclid=CjwKCAjwps75BRAcEiwAEiACMTjNZmt7-
    57. McCauley L, Markin C, Hosmer D. An unexpected consequence of electronic cigarette use. Chest. abril de 2012;141(4):1110-3. doi 10.1378/chest.11-1334
    58. Landman ST, Dhaliwal I, Mackenzie CA, Martinu T, Steele A, Bosma KJ. Life-threatening bronchiolitis related to electronic cigarette use in a Canadian youth. Can Med Assoc J. 2019;191(48):E1321-31. doi: 10.1503/cmaj.191402
    59. Balmes JR. Vaping-induced Acute Lung Injury: An Epidemic That Could Have Been Prevented. Am J Respir Crit Care Med. 2019;200(11):1342-4. doi: 10.1164/rccm.201910-1903ED
    60. Bonilla A, Blair AJ, Alamro SM, Ward RA, Feldman MB, Dutko RA, et al. Recurrent spontaneous pneumothoraces and vaping in an 18-year-old man: a case report and review of the literature. J Med Case Report. 2019;13(1):283. doi: 10.1186/s13256-019-2215-4
    61. Johnston LD, Miech RA, O’Malley PM, Bachman JG, Schulenberg JE, Patrick ME. Monitoring the Future National Survey Results on Drug Use, 1975-2018: Overview, Key Findings on Adolescent Drug Use [Internet]. Institute for Social Research. Institute for Social Research; 2019 ene [citado el 26 de junio de 2023]. Disponible en: https://eric.ed.gov/?id=ED594190
    62. Blundell MS, Dargan PI, Wood DM. The dark cloud of recreational drugs and vaping. QJM Int J Med. 2018;111(3):145-8. doi: 10.1093/qjmed/hcx049
    63. Layden JE, Ghinai I, Pray I, Kimball A, Layer M, Tenforde MW, et al. Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin - Final Report. N Engl J Med. 2020;382(10):903-16. doi: 10.1056/NEJMoa1911614
    64. Schier JG. Severe Pulmonary Disease Associated with Electronic-Cigarette–Product Use — Interim Guidance. MMWR Morb Mortal Wkly Rep. 2019;68. doi: 10.15585/mmwr.mm6836e2
    65. Health CO on S and. Smoking and Tobacco Use; Electronic Cigarettes [Internet]. Centers for Disease Control and Prevention. 2020 [citado 11 de septiembre de 2020]. Disponible en: https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html
    66. Chaumont M, van de Borne P, Bernard A, Van Muylem A, Deprez G, Ullmo J, et al. Fourth generation e-cigarette vaping induces transient lung inflammation and gas exchange disturbances: results from two randomized clinical trials. Am J Physiol Lung Cell Mol Physiol. 2019;316(5):L705-19. doi: 10.1152/ajplung.00492.2018.
    67. Farsalinos KE, Tsiapras D, Kyrzopoulos S, Savvopoulou M, Voudris V. Acute effects of using an electronic nicotine-delivery device (electronic cigarette) on myocardial function: comparison with the effects of regular cigarettes. BMC Cardiovasc Disord. 2014;14(1):78. doi: 10.1186/1471-2261-14-78
    68. Fernández LF, Martínez IL, Carrasco UF. Utilidad del índice Tei en el mundo real. Revista de Ecocardiografía Práctica y Otras Técnicas de Imagen Cardíaca [Internet]. 2017;(6):53–6. doi: 10.37615/retic.n6a14
    69. Chaumont M, de Becker B, Zaher W, Culié A, Deprez G, Mélot C, et al. Differential Effects of E-Cigarette on Microvascular Endothelial Function, Arterial Stiffness and Oxidative Stress: A Randomized Crossover Trial. Sci Rep. 2018;8(1):10378. doi: 10.1038/s41598-018-28723-0.
    70. Hackshaw A, Morris JK, Boniface S, Tang J-L, Milenković D. Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports. BMJ. 2018;j5855. doi: 10.1136/bmj.j5855
    71. Pisinger C, Døssing M. A systematic review of health effects of electronic cigarettes. Prev Med. diciembre de 2014; 69:248-60. doi: 10.1016/j.ypmed.2014.10.009
    72. Farsalinos KE, Polosa R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Ther Adv Drug Saf. 2014;5(2):67-86. doi: 10.1177/2042098614524430
    73. Madison MC, Landers CT, Gu B-H, Chang C-Y, Tung H-Y, You R, et al. Electronic cigarettes disrupt lung lipid homeostasis and innate immunity independent of nicotine. J Clin Invest. 2019;129(10):4290-304. doi: 10.1172/JCI128531
    74. Cho JH. The association between electronic-cigarette use and self-reported oral symptoms including cracked or broken teeth and tongue and/or inside-cheek pain among adolescents: A cross-sectional study. PLoS ONE. 2017;12(7). doi: 10.1371/journal.pone.0180506
    75. Manuela R, Mario M, Vincenzo R, Filippo R. Nicotine stimulation increases proliferation and matrix metalloproteinases-2 and -28 expression in human dental pulp cells. Life Sci. 2015;135:49-54. doi: 10.1016/j.lfs.2015.04.027
    76. Huang R, Li M, Gregory RL. Effect of nicotine on growth and metabolism of Streptococcus mutans. Eur J Oral Sci. 2012;120(4):319-25. doi: 10.1111/j.1600-0722.2012.00971.x
    77. Arnaout A, Khashaba H, Dobbs T, Dewi F, Pope-Jones S, Sack A, et al. The Southwest UK Burns Network (SWUK) experience of electronic cigarette explosions and review of literature. Burns J Int Soc Burn Inj. 2017;43(4):e1-6. doi: 10.1016/j.burns.2017.01.008
    78. Treitl D, Solomon R, Davare DL, Sanchez R, Kiffin C. Full and Partial Thickness Burns from Spontaneous Combustion of E-Cigarette Lithium-Ion Batteries with Review of Literature. J Emerg Med. 2017;53(1):121-5. doi: 10.1016/j.jemermed.2017.03.031
    79. McKenna LA. Electronic Cigarette Fires and Explosions in the United States 2009 – 2016 [Internet]. U.S. Fire Administration; 2017 [citado 11 de septiembre de 2020]. Disponible en: https://www.usfa.fema.gov/downloads/pdf/publications/electronic_cigarettes.pdf
    80. Tzortzi A, Kapetanstrataki M, Evangelopoulou V, Behrakis P. A Systematic Literature Review of E-Cigarette-Related Illness and Injury: Not Just for the Respirologist. Int J Environ Res Public Health. 2020;17(7). doi: 10.3390/ijerph17072248
    81. Lazutka FA, Vasiliauskene AP, Gefen SG. [On the toxicological assessment of the insecticide nicotine sulfate]. Gig Sanit. mayo de 1969;34(5):30-3.
    82. Mayer B. How much nicotine kills a human? Tracing back the generally accepted lethal dose to dubious self-experiments in the nineteenth century. Arch Toxicol. 2014;88(1):5-7. doi: 10.1007/s00204-013-1127-0
    83. Belkoniene M, Socquet J, Njemba-Freiburghaus D, Pellaton C. Near fatal intoxication by nicotine and propylene glycol injection: a case report of an e-liquid poisoning. BMC Pharmacol Toxicol. 2019;20(1):28. doi: 10.1186/s40360-019-0296-8
    84. Brieger K, Schiavone S, Miller Jr. FJ, Krause K-H. Reactive oxygen species: from health to disease. Swiss Med Wkly. 2012;142(3334). doi: 10.4414/smw.2012.13659
    85. Varlet V, Farsalinos K, Augsburger M, Thomas A, Etter J-F. Toxicity Assessment of Refill Liquids for Electronic Cigarettes. Int J Environ Res Public Health. 2015;12(5):4796-815. doi: 10.3390/ijerph120504796
    86. Wharton JD, Kozek LK, Carson RP. Increased Seizure Frequency Temporally Related to Vaping: Where There’s Vapor, There’s Seizures? Pediatr Neurol. 2020;104:66-7. doi: 10.1016/j.pediatrneurol.2019.10.006
    87. Agency for Toxic Substances and Disease Registry. Toxicological Profiles [Internet]. 2023 [citado el 26 de junio de 2023]. Disponible en: https://www.atsdr.cdc.gov/toxprofiledocs/index.html
    88. Talih S, Balhas Z, Eissenberg T, Salman R, Karaoghlanian N, El Hellani A, et al. Effects of User Puff Topography, Device Voltage, and Liquid Nicotine Concentration on Electronic Cigarette Nicotine Yield: Measurements and Model Predictions. Nicotine Tob Res. 2015;17(2):150-7. doi: 10.1093/ntr/ntu174
    89. Lee J, Cooke JP. The role of nicotine in the pathogenesis of atherosclerosis. Atherosclerosis. 2011;215(2):281 doi: 10.1016/j.atherosclerosis.2011.01.003
    90. Chowdhury P, Udupa KB. Nicotine as a mitogenic stimulus for pancreatic acinar cell proliferation. World J Gastroenterol. 2006;12(46):7428-32. doi: 10.3748/wjg.v12.i46.7428
    91. Goniewicz ML, Kuma T, Gawron M, Knysak J, Kosmider L. Nicotine levels in electronic cigarettes. Nicotine Tob Res Off J Soc Res Nicotine Tob. 2013;15(1):158-66. doi: 10.1093/ntr/nts103
    92. Trtchounian A, Talbot P. Electronic nicotine delivery systems: is there a need for regulation? Tob Control. 2011;20(1):47-52. doi: 10.1136/tc.2010.037259
    93. Davis B, Dang M, Kim J, Talbot P. Nicotine concentrations in electronic cigarette refill and do-it-yourself fluids. Nicotine Tob Res Off J Soc Res Nicotine Tob. 2015;17(2):134-41. doi: 10.1093/ntr/ntu080
    94. Fernández de Bobadilla J, Dalmau R, Saltó E. El cardiólogo ante el cigarrillo electrónico. Rev Esp Cardiol. 2015;68(4):286-9. doi: 10.1016/j.recesp.2014.08.014
    95. Stratton KR, Kwan LY, Eaton DL, National Academies of Sciences, Engineering, and Medicine (U.S.), editores. Public health consequences of e-cigarettes. Washington, DC: The National Academies Press; 2018. 750 p. (Consensus study report). ISNB: 978-0-309-46834-3
    96. Ramamurthi D, Chau C, Jackler RK. JUUL and other stealth vaporisers: hiding the habit from parents and teachers. Tob Control. 2018 doi: 10.1136/tobaccocontrol-2018-054455
    97. Conferencia de las Partes en el Convenio Marco de la OMS para el Control del Tabaco. Sistemas electrónicos de administración de nicotina y sistemas similares sin nicotina [Internet]. 2016. Disponible en: https://fctc.who.int/docs/librariesprovider12/meeting-reports/fctc-cop-7-11-es.pdf
    98. Pulido Álvarez A, Pinzón Silva DC, Rodríguez NI, Sandoval Salinas C, Pinzón Flórez CE, Díaz Ortega MH, et al. Opciones en Colombia para la regulación del uso de sistemas electrónicos con o sin dispensación de nicotina: un resumen de evidencias para política (policy brief) [Internet]. Cardiecol, Instituto de Evaluación Tecnológica en Salud - IETS y Fundación Colombiana del Corazón; 2018. Disponible en: https://www.iets.org.co/Archivos/3/Policy_brief_version_completa.pdf
    99. Chile. Ministerio de Salud. Subsecretaría de Salud Pública. Instituto De Salud Pública. Resolución 2994 exenta determina régimen de control a aplicar a los productos denominados genéricamente cigarrillos electrónicos, sus componentes y cualquier otro dispositivo similar que sea formulado sobre la base del principio activo nicotina [Internet]. nov 2, 2010. Disponible en: https://www.bcn.cl/leychile/navegar?idNorma=1018562
    100. Green SH, Bayer R, Fairchild AL. Evidence, Policy, and E-Cigarettes — Will England Reframe the Debate? N Engl J Med [Internet]. 2016;374(14):1301-3. doi: 10.1056/NEJMp1601154
    101. Bullen C, McRobbie H, Thornley S, Glover M, Lin R, Laugesen M. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. Tob Control. 2010;19(2):98-103. doi: 10.1136/tc.2009.031567
    102. El Dib R, Suzumura EA, Akl EA, Gomaa H, Agarwal A, Chang Y, et al. Electronic nicotine delivery systems and/or electronic non-nicotine delivery systems for tobacco smoking cessation or reduction: a systematic review and meta-analysis. BMJ Open. 23 de 2017;7(2):e012680. doi: 10.1136/bmjopen-2016-012680
    103. Cardenas VM, Fischbach LA, Chowdhury P. The use of electronic nicotine delivery systems during pregnancy and the reproductive outcomes: A systematic review of the literature. Tob Induc Dis. 2019;17:52. doi: 10.18332/tid/104724
    104. Prochaska JJ. The public health consequences of e‐cigarettes: a review by the National Academies of Sciences. A call for more research, a need for regulatory action. Addiction. 2019;114(4):587-587-9. doi: 10.1111/add.14478
    105. Holloway AC, Salomon A, Soares MJ, Garnier V, Raha S, Sergent F, et al. Characterization of the adverse effects of nicotine on placental development: in vivo and in vitro studies. Am J Physiol - Endocrinol Metab. 2014;306(4):E443-56. doi: 10.1152/ajpendo.00478.2013
    106. Muneoka K, Ogawa T, Kamei K, Mimura Y, Kato H, Takigawa M. Nicotine exposure during pregnancy is a factor which influences serotonin transporter density in the rat brain. Eur J Pharmacol. 2001;411(3):279-82. doi: 10.1016/s0014-2999(00)00925-0
    107. Chhabra D, Sharma S, Kho AT, Gaedigk R, Vyhlidal CA, Leeder JS, et al. Fetal lung and placental methylation is associated with in utero nicotine exposure. Epigenetics. 2014;9(11):1473-84. doi: 10.4161/15592294.2014.971593
    108. Suter MA, Mastrobattista J, Sachs M, Aagaard K. Is There Evidence for Potential Harm of Electronic Cigarette Use in Pregnancy? Birt Defects Res A Clin Mol Teratol 2015;103(3). doi: 10.1002/bdra.23333
    109. Seidler RD, Bernard JA, Burutolu TB, Fling BW, Gordon MT, Gwin JT, et al. Motor control and aging: Links to age-related brain structural, functional, and biochemical effects. Neuroscience & Biobehavioral Reviews.2010;34(5):721–33. doi: 10.1016/j.neubiorev.2009.10.005
    110. Abdel-Rahman, N.M. Alaniz, M.A. Saleh. Nematicidal activity of terpenoids Molecules, 2013, 3(48), pp. 16-22 doi: 10.1080/03601234.2012.716686
    111. Sanabria C Juan Sebastián, Arce S Jaime David, Sierra O Orlenis María, Gil V Aura María. Tabaquismo materno como un factor posiblemente implicado en el desarrollo de la obesidad infantil. Rev. chil. obstet. ginecol. 2016; 81(6): 526-533. doi: 10.4067/S0717-75262016000600013
    112. Gao J. Guidelines for the routine application of the peptide hits technique. J Am Soc Mass Spectrom, 2005, 16(8):1231-8. doi: 10.1016/j.jasms.2004.12.002
    113. Holloway AC, Kellenberger LD, Petrik JJ. Fetal and neonatal exposure to nicotine disrupts ovarian function and fertility in adult female rats. Endocrine. 2006;30:213–216. doi: 10.1385/ENDO:30:2:213
    114. Holloway AC, Lim GE, Petrik JJ, Foster WG, Morrison KM, Gerstein HC. Fetal and neonatal exposure to nicotine in Wistar rats results in increased beta cell apoptosis at birth and postnatal endocrine and metabolic changes associated with type 2 diabetes. Diabetologia. 2005;48:2661–2666 doi: 10.1007/s00125-005-0022-5
    115. Petrik JJ, Gerstein HC, Cesta CE, Kellenberger LD, Alfaidy N, Holloway AC. Effects of rosiglitazone on ovarian function and fertility in animals with reduced fertility following fetal and neonatal exposure to nicotine. Endocrine. 2009;36(2):281-90. doi: 10.1007/s12020-009-9229-4
    116. Lawrence PA, Struhl G, Casal J. Planar Cell Polarity: A Bridge Too Far? Current Biology. 2008;18(20):R959–61. doi: 10.1016/j.cub.2008.09.002
    117. Calderon CPG, Vargas YAC, Forero-Forero JC. Lesión pulmonar asociada al uso de cigarrillos electrónicos o productos de vapeo (EVALI): a propósito de un caso relacionado a neumonía eosinofílica aguda. Revista Colombiana de Neumología. 2022;34(1):46–51. doi: 10.30789/rcneumologia.v34.n1.2022.559
    118. Salzman GA, Alqawasma M, Asad H. Vaping Associated Lung Injury (EVALI): An Explosive United States Epidemic. Mo Med. 2019;116(6):492.
    119. Nagarathna PKM, Wesley M, Reddy P, Reena K. Review on genotoxicity, its molecular mechanisms and prevention. International Journal of Pharmaceutical Sciences Review and Research.2013;22:236–43.
    120. Lerner CA, Sundar IK, Yao H, Gerloff J, Ossip DJ, McIntosh S, et al. Vapors produced by electronic cigarettes and e-juices with flavorings induce toxicity, oxidative stress, and inflammatory response in lung epithelial cells and in mouse lung. PloS One. 2015;10(2):e0116732. doi: 10.1371/journal.pone.0116732
    121. Primack BA, Soneji S, Stoolmiller M, Fine MJ, Sargent JD. Progression to Traditional Cigarette Smoking After Electronic Cigarette Use Among US Adolescents and Young Adults. JAMA Pediatr. noviembre de 2015;169(11):1018-23. doi: 10.1001/jamapediatrics.2015.1742
    Tutoriales

    Autores:

    ¿Cómo enviar un artículo?

    Par evaluador:

    ¿Cómo evaluar un artículo?

    Información

    Historia de la revista

    Palabras clave

    Directorios e indexadores

     

    Patrocinadores

     Nos apoyan + Info Aquí 

    Perfil de Google Scholar

    Más leídos en los últimos 30 días

    Número actual

    Código QR

    Sistema OJS 3.4.0.7 - Metabiblioteca |